과제정보
This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1A2C1100974).
참고문헌
- Vaidya SR, Yarrarapu SNS, Aeddula NR. Nephrocalcinosis [Internet]. Treasure Island: StatPearls Publishing; 2021 Aug [cited 2022 Apr 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537205/.
- Ronnefarth G, Misselwitz J; Members of the Arbeitsgemeinschaft fur padiatrische Nephrologie. Nephrocalcinosis in children: a retrospective survey. Pediatr Nephrol 2000;14:1016-21. https://doi.org/10.1007/s004670050065
- Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int 2011;80:1278-91. https://doi.org/10.1038/ki.2011.336
- Hoppe B, Kemper MJ. Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 2010;25:403-13. https://doi.org/10.1007/s00467-008-1073-x
- Lietman SA, Germain-Lee EL, Levine MA. Hypercalcemia in children and adolescents. Curr Opin Pediatr 2010;22:508-15. https://doi.org/10.1097/MOP.0b013e32833b7c23
- De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype. Clin Chem Lab Med 2019;57:1650-67. https://doi.org/10.1515/cclm-2018-1208
- Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410-21. https://doi.org/10.1056/NEJMoa1103864
- Gil A, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab 2018;72:87-95. https://doi.org/10.1159/000486536
- Marks BE, Doyle DA. Idiopathic infantile hypercalcemia: case report and review of the literature. J Pediatr Endocrinol Metab 2016;29:127-32.
- Janiec A, Halat-Wolska P, Obrycki L, Ciara E, Wojcik M, Pludowski P, et al. Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations. Nephrol Dial Transplant 2021;36:1484-92. https://doi.org/10.1093/ndt/gfaa178
- Vogiatzi MG, Jacobson-Dickman E, DeBoer MD; Drugs, and Therapeutics Committee of The Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab 2014;99:1132-41. https://doi.org/10.1210/jc.2013-3655
- Kang SJ, Lee R, Kim HS. Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report. Ann Pediatr Endocrinol Metab 2019;24:64-7. https://doi.org/10.6065/apem.2019.24.1.64
- Lee GM, Moon JE, Kim HA, Lee SJ, Ko CW. A novel variant of SLC34A1 gene in an infant with idiopathic infantile hypercalcemia. ESPE Abstr 2018;89:P2-047.
- Barnett ML. Hypercalcemia. Semin Oncol Nurs 1999;15:190-201. https://doi.org/10.1016/S0749-2081(99)80007-2
- Moza D, Dasgupta K, Daskalopoulou S. Hypercalcemia and upper GI symptoms. Can J Gen Int Med 2018;13:51-2.